Combination therapy: ICI + TKI
May 13, 2025PF AE considered related to TKI
May 13, 2025AE possibly related to both ICI and TKI
G≤1 or tolerable G2
- continue both agents
- supportive care
- monitor for signs of worsening
CTCAE grading
grade 1: mild (a/paucisymptomatic)
grade 2: moderate (minimal symptoms)
grade 3: severe (hospitalisation often required)
grade 4: life threatening